|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/47 | (2006.01) |
| C07D 215/50 | (2013.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61K 31/47 | (2013.01) | ||
| C07D 215/50 | (2006.01) | ||
| A61P 11/00 | (2018.01) |
| (11) | Number of the document | 3315131 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16814513.4 |
| Date of filing the European patent application | 2016-06-24 | |
| (97) | Date of publication of the European application | 2018-05-02 |
| (45) | Date of publication and mention of the grant of the patent | 2022-09-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2016/068902 |
| Date | 2016-06-24 |
| (87) | Number | WO 2016/208744 |
| Date | 2016-12-29 |
| (30) | Number | Date | Country code |
| 2015127788 | 2015-06-25 | JP |
| (72) |
FUJIOKA, Akio , JP
|
| (73) |
Taiho Pharmaceutical Co., Ltd. ,
1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444,
JP
|
| (54) | THERAPEUTIC AGENT FOR FIBROSIS |
| THERAPEUTIC AGENT FOR FIBROSIS |